STRAVIX◊ Umbilical Tissue Products

Structural placental tissue comprised of human umbilical cord, preserved to retain native tissue components to help manage challenging wounds and compromised surgical sites to help patients get back to their lives1,2

STRAVIX-HERO-1-840x840-PX.png

Designed to be different

STRAVIX PL◊ Lyopreserved Umbilical Tissue and STRAVIX Cryopreserved Umbilical Tissue are highly versatile, with both wound and surgical applications:

  • Shown to improve the closure rates of challenging wounds as a cover,3 including those with exposed structures or hardware
  • Suitable as a cover for tendon, ligament, bone, nerve repair or soft tissue sites across a wide range of surgical procedures from head to toe, particularly those involving high-risk patients
  • Provide a barrier under incisions

Manufactured using proprietary lyopreservation or cryopreservation processes, blood vessels are removed to prevent an immune response while retaining growth factors and an extracellular matrix rich in hyaluronic acid.1,2

STRAVIX-HERO-2-840x840-PX.png

Product Features

How to apply STRAVIX PL and STRAVIX Tissues

STRAVIX Tissues offer advanced modalities that can be used to cover hard-to-heal wounds, including:

  • Diabetic foot ulcers
  • Dehisced wounds
  • Venous leg ulcers
  • Pressure injuries
  • Traumatic wounds
  • Surgical wounds

Customer Information

Please see each products’ Instructions for Use for important safety information including approved uses.

STRAVIX PL & STRAVIX Customer Care:

  • T: 888-674-9551
  • F 443-283-4419

◊Osiris, STRAVIX PL and STRAVIX Tissue are trademarks of Osiris Therapeutics, Inc., a wholly owned direct subsidiary of Smith+Nephew Consolidated, Inc.
All Trademarks acknowledged.


Recall and Complaints

Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.

Terms & Conditions and Warranties

 

Citations

1. Dhall S, et al. Bioact Mater. 2018; 4(1): 97-106.

2. Data on file at Osiris Therapeutics, Inc

3. Woo KY. Woundsource (White Paper) 2014.

Title

Text

Explore